APA (7th ed.) Citation

Stopeck, A. T., Fizazi, K., Body, J., Brown, J. E., Carducci, M., Diel, I., . . . Braun, A. (2016). Safety of long-term denosumab therapy: Results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer. Supportive care in cancer, 24(1), 447-455. https://doi.org/10.1007/s00520-015-2904-5

Chicago Style (17th ed.) Citation

Stopeck, Alison T., et al. "Safety of Long-term Denosumab Therapy: Results from the Open Label Extension Phase of Two Phase 3 Studies in Patients with Metastatic Breast and Prostate Cancer." Supportive Care in Cancer 24, no. 1 (2016): 447-455. https://doi.org/10.1007/s00520-015-2904-5.

MLA (9th ed.) Citation

Stopeck, Alison T., et al. "Safety of Long-term Denosumab Therapy: Results from the Open Label Extension Phase of Two Phase 3 Studies in Patients with Metastatic Breast and Prostate Cancer." Supportive Care in Cancer, vol. 24, no. 1, 2016, pp. 447-455, https://doi.org/10.1007/s00520-015-2904-5.